Okomera

Okomera

Biotechnology Research

Automated 3D organoid screening technology

About us

We integrate standard assays on chip (eg. CRISPR, T-cell, cytotoxicity) to accelerate drug discovery from target to validation, and advance preclinical predictivity

Industry
Biotechnology Research
Company size
11-50 employees
Headquarters
Paris
Type
Privately Held
Founded
2020

Locations

Employees at Okomera

Updates

Similar pages

Browse jobs

Funding

Okomera 4 total rounds

Last Round

Grant

US$ 1.6M

Investors

Bpifrance
See more info on crunchbase